Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment

Chih Hsin Yang, Min Chun Chen, Ann Lii Cheng, Chih Hung Hsu, Kun Huei Yeh, Yu Chie Yu, Jacqueline Whang-Peng, Pan Chyr Yang

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science